Welcome to Bristol Myers Squibb Washington

Bristol Myers Squibb’s robust and growing presence in Washington state is transforming the way difficult-to-treat cancers are approached.

Our teams in Seattle and Bothell discover, develop, manufacture and commercialize therapies in Immuno-Oncology (I-O) and cell therapy. Through continued leadership in the rapidly developing fields of engineered cell-based therapies and biotherapeutics aimed at harnessing the power of immune cells to enhance or restore the body’s ability to fight cancer, we seek to advance novel treatments for cancer patients with precision and purpose. 

Meet our team

Learn about our leaders who are making a difference in Washington state.

Teri Foy and her work at Bristol Myers Squibb >

Teresa (Teri) Foy, Ph.D., is an immunologist with more than 25 years of biotechnology and pharmaceutical industry experience developing novel therapeutics in the areas of oncology and inflammation.

Justine Dell’Aringa and her work at Bristol Myers Squibb >

Justine Dell’Aringa is an associate director of Translational Medicine, working in Bristol Myers Squibb’s Immuno-Oncology and Cell Therapy Thematic Research Center. 

Join us as we transform patient lives through science 

Everyday, each of us work to improve outcomes of patients fighting serious diseases. Together we’re building a better future for each other and the patients who need us the most. 

Driving innovation forward in Washington state

Learn about our broad scope of scientific innovation in Washington state.

Confronting the complexities of cancer >

Bristol Myers Squibb is driven to understand human biology and the complexities of cancer in order to advance the next generation of cancer therapies.

Looking to the future of cell therapy >

Bristol Myers Squibb is pursuing a multitude of diverse approaches in cell therapy to attack disease from new perspectives. 

Blueprint for a breakthrough: Applying research learnings beyond the lab >

With multiple cell-based therapeutic approaches under investigation in blood cancers and beyond, Bristol Myers Squibb researchers like Justine Dell’Aringa are harnessing the immune system to reimagine the future of cancer treatment.

Cell therapy’s got talent – and is looking for more >

Major recruitment efforts are underway at Bristol Myers Squibb.

‘Serial killer’ CAR T cells target and destroy tumor cells in Bristol Myers Squibb lab >

BMS is a leader in autologous chimeric antigen receptor (CAR) T cell therapy, a type of cancer immunotherapy where a patient’s own T cells are genetically engineered to recognize and bind to proteins found on the surface of certain cancer cells. This video, shared by the Discovery Research team of the Immuno-Oncology and Cell Therapy (IO-CT) thematic research center (TRC) in Seattle, Washington, shows a tumor cell being destroyed by CAR T cells. 

Community impact

Learn how we are making a difference in communities across Washington state.

People and business resource groups >

People and Business Resource Groups (PBRGs) represent one key strategy we use to support the business objectives, career advancement and development needs of our employees.

In pursuit of more female scientists: Breaking barriers for women in STEM >

Teri Foy, Ph.D., discusses her advocacy for women in STEM and frequently meets and presents to girls and women at schools in the Seattle area. 

Improving science education >

We support programs and organizations that address unmet medical needs, help students grow through STEM education, and deliver basic human services to our neighbors.

Washington state regional fact sheet >

Learn more about our impact in Washington

Smile, you’re on camera, talking STEM >

Through a partnership with Seattle’s Pacific Science Center, nearly 30 Bristol Myers Squibb scientists shared their STEM expertise with the next generation.

Additional resources

Learn more about our scientific approaches and innovation.

Understanding immuno-oncology resistance >

Learn more about resistance to immunotherapy and new research evaluating these mechanisms.

Cell therapy resources >

Discover how cell therapies are unlocking new potential in cancer research.

Cell therapy manufacturing infographic >

Bristol Myers Squibb is advancing cell therapy research through novel manufacturing approaches and a well-established supply chain platform across a broad network of state-of-the-art facilities with cutting-edge technologies and highlight trained manufacturing teams.

Translational medicine >

With a long history of translating scientific learnings into transformational medicines, Bristol Myers Squibb is currently seeking a more precise understanding of how discoveries and treatments impact each patient.